在小鼠中比较七种与propargyl相关的抗叶酸抗生素的药理动力学
John Hoody1, Jeremy B Alverson1, Santosh Keshipeddy2
1Department of Chemistry and Biochemistry, The University of Montana, Missoula, MT 59812, United States.
概括
新型抗叶酸化合物对MRSA和VISA等耐药细菌表现出强烈的活性. 化合物38C1表现出有前途的药理动力学和口服生物可用性,使其成为进一步开发抗药性感染的主要候选者.
科学领域:
- 药理学和药物化学 药理学和药物化学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 抗微生物药物耐药性 (AMR) 是一个主要的全球健康威胁,由抗甲素耐药的黄金葡萄球菌 (MRSA) 和抗万科胺素耐药菌株 (VISA) 等病原体驱动.
- 现有的抗生素越来越无效,需要开发新的治疗药物来对抗耐药细菌感染.
研究的目的:
- 为了评估新型的propargyl-linked diaminopyrimidine dihydrofolate reductase (DHFR) 抑制剂的药理动力学特性.
- 识别具有强效抗药性细菌活性的候选物,包括MRSA和VISA菌株.
主要方法:
- 开发和验证一个LC-QQQ生物分析方法的七个diaminopyrimidine类似物.
- 在小鼠模型中通过静脉注射 (IV),腹腔内 (IP) 和口服 (PO) 进行药理动力学研究.
- 对药物动力学参数的分析,包括半衰期,AUC,Cmax和口服生物可用性.
主要成果:
- 化合物38C1具有良好的溶解性,最高耐受剂量高,口服生物利用率为20%.
- 药物动力学与MIC比率分析证实,38C1的血度保持在MRSA和VISA菌株的MIC值以上.
- 在不同的施用途径中观察到药物动力学参数的显著变化.
结论:
- 化合物38C1是一种有希望的抗叶酸候选物,用于治疗耐药细菌引起的感染.
- 需要进一步的研究来评估38C1在感染模型中的有效性,并优化传递策略.
相关概念视频
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...